- Corporate Officers - P
- Parmar Kush
Insider Trading History of Parmar Kush
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Parmar Kush since 2018.
This trader's CIK number is 1664281.
At the time of last reporting, Parmar Kush was the Officer of Entrada Therapeutics, Inc.. (stock ticker symbol TRDA).
Also see all insider trading activities at Entrada Therapeutics, Inc..
Note that in the past
PARMAR KUSH also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Akouos, Inc. (AKUS) by Parmar Kush
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | AKUS | 294,117 | $4,999,989 | 470,000 | $8,460,000 | 0 | $0 |
Yearly summary of insider trading at Rallybio Corp (RLYB) by Parmar Kush
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | RLYB | 0 | $0 | 100,000 | $819,999 | 0 | $0 |
2022 | RLYB | 0 | $0 | 460,000 | $5,915,500 | 0 | $0 |
2021 | RLYB | 615,384 | $7,999,992 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Q32 Bio Inc. (FIXX) by Parmar Kush
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | FIXX | 0 | $0 | 1,000,000 | $12,645,000 | 0 | $0 |
2019 | FIXX | 0 | $0 | 615,000 | $13,204,050 | 0 | $0 |
2018 | FIXX | 0 | $0 | 571,157 | $11,622,915 | 0 | $0 |
Yearly summary of insider trading at Entrada Therapeutics, Inc. (TRDA) by Parmar Kush
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | TRDA | 0 | $0 | 152,000 | $1,069,204 | 0 | $0 |
2021 | TRDA | 250,000 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vor Biopharma Inc. (VOR) by Parmar Kush
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | VOR | 555,555 | $9,999,990 | 330,706 | $5,059,801 | 0 | $0 |
Yearly summary of insider trading at Cincor Pharma, Inc. (CINC) by Parmar Kush
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | CINC | 470,000 | $7,520,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Camp4 Therapeutics Corp (CAMP) by Parmar Kush
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | CAMP | 909,090 | $9,999,990 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aprea Therapeutics, Inc. (APRE) by Parmar Kush
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | APRE | 0 | $0 | 640,000 | $20,669,735 | 0 | $0 |
2019 | APRE | 333,333 | $4,999,995 | 0 | $0 | 0 | $0 |
Insider trading activities at 8 companies by Parmar Kush:
1. Akouos, Inc. (AKUS)
2. Rallybio Corp (RLYB)
3. Q32 Bio Inc. (FIXX)
4. Entrada Therapeutics, Inc. (TRDA)
5. Vor Biopharma Inc. (VOR)
6. Cincor Pharma, Inc. (CINC)
7. Camp4 Therapeutics Corp (CAMP)
8. Aprea Therapeutics, Inc. (APRE)
Table 1. Insider trading of Akouos, Inc. (AKUS) by Parmar Kush
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-12-29 | AKUS | Sale | 470,000 | 18.00 | 8,460,000 |
2020-06-30 | AKUS | Buy | 294,117 | 17.00 | 4,999,989 |
Table 2. Insider trading of Rallybio Corp (RLYB) by Parmar Kush
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-03-07 | RLYB | Sale | 100,000 | 8.20 | 819,999 |
2022-06-03 | RLYB | Sale | 150,000 | 12.50 | 1,875,000 |
2022-05-23 | RLYB | Sale | 100,000 | 13.00 | 1,300,000 |
2022-02-08 | RLYB | Sale | 210,000 | 13.05 | 2,740,500 |
2021-08-02 | RLYB | Buy | 615,384 | 13.00 | 7,999,992 |
Table 3. Insider trading of Q32 Bio Inc. (FIXX) by Parmar Kush
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-12-22 | FIXX | Sale | 500,000 | 12.82 | 6,410,000 |
2020-12-14 | FIXX | Sale | 500,000 | 12.47 | 6,235,000 |
2019-05-16 | FIXX | Sale | 615,000 | 21.47 | 13,204,050 |
2018-12-10 | FIXX | Sale | 15,575 | 26.00 | 405,027 |
2018-11-23 | FIXX | Sale | 29,682 | 20.04 | 594,708 |
2018-11-16 | FIXX | Sale | 525,900 | 20.20 | 10,623,180 |
Table 4. Insider trading of Entrada Therapeutics, Inc. (TRDA) by Parmar Kush
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-07-09 | TRDA | Sale | 27,000 | 7.50 | 202,554 |
2025-06-27 | TRDA | Sale | 75,000 | 6.91 | 518,250 |
2025-07-01 | TRDA | Sale | 25,000 | 7.12 | 178,075 |
2025-06-30 | TRDA | Sale | 25,000 | 6.81 | 170,325 |
2021-11-02 | TRDA | Buy | 250,000 | 20.00 | 5,000,000 |
Table 5. Insider trading of Vor Biopharma Inc. (VOR) by Parmar Kush
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-11-16 | VOR | Sale | 330,706 | 15.30 | 5,059,801 |
2021-02-09 | VOR | Buy | 555,555 | 18.00 | 9,999,990 |
Table 6. Insider trading of Cincor Pharma, Inc. (CINC) by Parmar Kush
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-01-11 | CINC | Buy | 470,000 | 16.00 | 7,520,000 |
Table 7. Insider trading of Camp4 Therapeutics Corp (CAMP) by Parmar Kush
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-10-15 | CAMP | Buy | 909,090 | 11.00 | 9,999,990 |
Table 8. Insider trading of Aprea Therapeutics, Inc. (APRE) by Parmar Kush
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-06-16 | APRE | Sale | 140,000 | 33.30 | 4,662,000 |
2020-06-11 | APRE | Sale | 245,000 | 28.75 | 7,044,485 |
2020-05-19 | APRE | Sale | 255,000 | 35.15 | 8,963,250 |
2019-10-07 | APRE | Buy | 333,333 | 15.00 | 4,999,995 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Parmar Kush
(Officer of Entrada Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.